08-07-2026 16:17 via prnewswire.com

Tsingke Highlights AI-Driven CLDN18.2 Antibody Discovery at AIS 2026

MONTPELLIER, France, July 8, 2026 /PRNewswire/ -- Tsingke, a provider of integrated life science research solutions, participated in the Antibody Industrial Symposium (AIS) 2026, one of Europe's leading conferences dedicated to therapeutic antibodies and biotherapeutics. At the event, the...
Read more »